4//SEC Filing
Subramanian Sanjay 4
Accession 0001209191-23-021202
CIK 0001693011other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 4:05 PM ET
Size
5.5 KB
Accession
0001209191-23-021202
Insider Transaction Report
Form 4
Subramanian Sanjay
SVP, CFO & Head of BD
Transactions
- Award
Stock option (right to buy)
2023-03-23+135,000→ 135,000 totalExercise: $3.30Exp: 2033-03-22→ Common Stock (135,000 underlying)
Footnotes (1)
- [F1]The option was granted on March 23, 2023. The shares underlying the option are scheduled to vest in equal monthly installments from April 23, 2023 through March 23, 2027.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001790246
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 4:05 PM ET
- Size
- 5.5 KB